Impact of environmental exposures on tumor risk in SDHx mutation carriers
Official title: Impact of Environmental Exposures on Tumor Risk in Subjects at Risk of Hereditary SDHx-related Paragangliomas - National Study
Run by Assistance Publique - Hôpitaux de Paris · NCT06408402 · Data updated 2026-11-12
This study tests whether exposure to SDHi chemicals from work, home, or the environment affects tumor development in people with SDHx gene mutations.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1300 (estimated) |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 20 sites (Angers and 19 other locations) |
| Status | Recruiting |
| Started | May 22, 2024 |
| Main results expected | May 22, 2028 |
| Study ends | May 22, 2028 |
| Registry record updated | July 9, 2026 |
| Trial ID | NCT06408402 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
SDHx mutation carriers who have or have not developed an SDHx-related tumor, willing to complete questionnaires and provide a blood sample.
✕Probably not a fit
Individuals without SDHx mutations or without exposure to SDHi risks may have little personal benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study compares SDHx mutation carriers who have developed SDHx-related tumors with those who have not. Past environmental and occupational exposures are collected via a telephone questionnaire, and a blood sample is offered. Cases and controls are matched by age and affected gene to explore the link between SDHi exposure and tumor risk. The lead sponsor is AP-HP, with collaboration from INSA, ANSES, and Centre Leon Berard, across several French centers.
Why it matters
Potential benefit: If associations are found, this could inform risk reduction and monitoring strategies for SDHx mutation carriers.
How similar studies have gone: Other studies have explored environmental factors in SDHx-related tumors, but definitive links remain to be established; this study adds targeted exposure data.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Cases: SDHx mutation carriers diagnosed for a SDHx-related tumor * Controls: SDHx mutation carriers with no SDHx-related tumor Exclusion Criteria: * Incapacity to exercise free and informed consent for the study * Patient under tutorship or guardianship or legal safeguard
Where it's running
-
Hôpital européen Georges Pompidou - APHP
Paris, France Recruiting -
CHU d'Angers
Angers, France Active not recruiting -
CHU Jean Minjoz Besançon
Besançon, France Active not recruiting -
Hôpital Louis Pradel
Bron, France Active not recruiting -
CHU de Caen
Caen, France Active not recruiting -
Hôpital Michalon - CHU Grenoble
Grenoble, France Active not recruiting
Show 14 more locations
-
CHU de Lille - Hôpital HURIEZ
Lille, France Active not recruiting -
Hopital de la Conception - Marseille
Marseille, France Active not recruiting -
CHU de Montpellier - Hôpital Lapeyronie
Montpellier, France Active not recruiting -
CHU de Nantes
Nantes, France Active not recruiting -
CHU de Nice -Hôpital Archet 2
Nice, France Active not recruiting -
Hôpital Pitié-Salpêtrière - APHP
Paris, France Active not recruiting -
Hôpital Cochin - APHP
Paris, France Active not recruiting -
Hôpital européen Georges Pompidou - APHP
Paris, France Active not recruiting -
CHU de Poitiers
Poitiers, France Active not recruiting -
CHU de Rennes - Hôpital Sud
Rennes, France Active not recruiting -
Hôpitaux universitaire de Strasbourg - Hôpital de Hautepierre
Strasbourg, France Active not recruiting -
CHU de Toulouse - Hôpita Larrey
Toulouse, France Active not recruiting -
CHU Bretonneau
Tours, France Active not recruiting -
Institut Gustave Roussy
Villejuif, France Active not recruiting
Study contacts
- Study coordinator: Alexandre Buffet, MD, PhD
- Email: alexandre.buffet@aphp.fr
- Phone: 33-1-56093879
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cadmium Exposure in Pregnancy and Its Effect on Fetal Growth
This observational study follows pregnant people to see how cadmium exposure relates to fetal growth and birth weight.
-
Probiotic supplement to lower serum PFAS levels in male firefighters
A probiotic supplement containing Streptococcus salivarius is being tested to see if it lowers PFAS levels in male firefighters who have been exposed to PFAS.
-
Prenatal education to reduce environmental exposures during pregnancy
Aimed at pregnant people, this program tests whether a classroom-style education can help reduce exposure to harmful pollutants from seafood and nearby pollution sources.
-
How environment and biology together predict health, aging, and death
Researchers are following adults to see how living conditions and biology together relate to aging and life expectancy, by linking personal health data with environmental and social information over time.
-
PNEUMO-LIBS: Using tissue imaging and AI to explore causes of chronic lung diseases
This study tests whether multi-element tissue imaging with LIBS, plus the AI tool IFF, can help doctors understand possible causes of chronic lung diseases in adults who have had a lung biopsy.
-
Pemigatinib for advanced SDH‑deficient GIST
This trial will try the oral drug pemigatinib in adults with advanced SDH‑deficient GIST to see if it controls tumor growth and what side effects occur.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.